Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: βTrial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).β.
Zachariah Brown, Sheila Linden, Christina Rodriguez, Omer H. Elmadbouh, Jonathan A. Pachter +9 more
John Davelaar, Jessica Gai, Zachariah Brown, Abrahm Levi, Sheila Linden +15 more
Nicholas Bragagnolo, Christina Rodriguez, Gerald F. Audette, Arnold J. Apostol